Inventor

Theodore L. Parker

Inventor

Danville, CA, US

Overview

1984–2016

Patent span

Human necessities

Primary field (CPC A)

Patents· 62 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C08Gprimary

C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds16%

A61FFilters implantable into blood vessels12%

A61LMethods or apparatus for sterilising materials or objects in general11%

A61BDiagnosis7%

A61MDevices for introducing media into, or onto, the body7%

G02BOptical elements, systems or apparatus7%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%

Y10TTechnical subjects covered by former us classification4%

A61KPreparations for medical, dental or toiletry purposes4%

B01DSeparation4%

PatentTitleYear

9,498,358'Implantable medical device with openings for delivery of beneficial agents with combination release kinetics'2016 9,327,060'Rapamycin reservoir eluting stent'2016 8,986,775'System and method for loading a beneficial agent into a medical device'2015 8,927,049'Adhesion promoting temporary mask for coated surfaces'2015 8,887,477'E beam sterilization of medical devices comprising bioactive coating'2014 8,673,336'Composition, system, and method for modulating release kinetics in implantable drug delivery devices by modifying drug solubility'2014 8,449,901'Implantable medical device with beneficial agent concentration gradient'2013 8,221,452'Systems and methods for sealing a vascular puncture'2012 7,955,639'System and method for loading a beneficial agent into a medical device'2011 7,927,650'System and method for loading a beneficial agent into a medical device'2011 7,819,914'Adhesion promoting primer for coated surfaces'2010 7,758,636'Expandable medical device with openings for delivery of multiple beneficial agents'2010 7,517,362'Therapeutic agent delivery device with controlled therapeutic agent release rates'2009 7,208,011'Implantable medical device with drug filled holes'2007 7,169,179'Drug delivery device and method for bi-directional drug delivery'2007 7,081,125'Universal introducer'2006 7,056,338'Therapeutic agent delivery device with controlled therapeutic agent release rates'2006 6,743,248'Pretreatment method for enhancing tissue adhesion'2004 6,733,515'Universal introducer'2004 6,562,059'Vascular sealing device with microwave antenna'2003 6,306,125'Angiogenic implant delivery system and method'2001 6,302,898'Devices for sealing punctures in body vessels'2001 6,263,880'Method of enhancing blood flow in tissue'2001 6,099,283'Apparatus for formation of on-site coated and tinted optical elements'2000 6,039,757'In situ formed fenestrated stent'2000 6,037,280'Ultraviolet ray (UV) blocking textile containing particles'2000 6,033,401'Vascular sealing device with microwave antenna'2000 5,916,669'Enhanced abrasion resistance radiation curable coating for substrates'1999 5,910,375'Tintable, scratch resistant coatings for plastic ophthalmic lenses'1999 5,899,917'Method for forming a stent in situ'1999 5,770,259'Quantitative tinting'1998 5,733,483'Method for formation of on-site coated and tinted optical elements'1998 5,414,053'Thermoformable, thermosettable adhesives prepared from epoxy resins and polyesters and/or polycarbonates'1995 5,409,524'Membranes having improved selectivity and recovery, and process for making same'1995 5,373,578'Strippable coating for optical fiber'1994 5,225,586'Benzocyclobutene capped fluoroalkyl aromatic based fluoroarylether monomers, oligomers, and reaction products'1993 5,182,344'Curing polyester or polycarbonate and polyepoxide with polyorgano phosphorous catalyst'1993 5,156,656'Semi-permeable membranes derived from reactive oligomers'1992 5,124,430'Arylene carbonate cyanoaryl ether copolymer'1992 5,105,006'Phosphonium salts'1992 5,082,921'Benzotrifluoride aryl ether polymer'1992 5,045,632'Novel bis(phosphoranylidene) ammonium salts'1991 5,037,903'Composition of aromatic polyester copolyester carbonate or polycarbonate with polyepoxide and polyorgano phosphorous catalyst'1991 5,034,034'Novel aryl carbonate cyanoaryl ether gas separation membranes'1991 5,030,252'Novel benzotrifluoride aryl ether gas separation membranes'1991 5,007,706'Polymeric optical fiber'1991 4,950,722'Unsaturated epoxy moiety, unsaturated monomer and liquid epoxy compound solution'1990 4,909,597'Flexible optical waveguide containing a thermoplastic aliphatic segmented polyurethane core'1990 4,893,897'Plastic optical fiber for in vivo use having a biocompatible polyurethane cladding'1990 4,867,531'Plastic optical fiber for in vivo use having a biocompatible polysiloxane cladding'1989 4,836,646'Plastic optical fiber for in vivo use having a bio-compatible polyureasiloxane copolymer, polyurethane-siloxane copolymer, or polyurethaneureasiloxane copolymer cladding'1989 4,783,519'High functionality, low melt viscosity, flakable solid epoxy resin with good heat resistance'1988 4,764,580'High functionality, low melt viscosity, flakable solid epoxy resin with good heat resistance'1988 4,725,663'Use of n-glycidyl benzoxazoles as latently cross-linkable reactive diluents for epoxy resins'1988 4,717,760'Fluorinated tris-epoxides based on triphenyl methane'1988 4,716,204'Use, as latent cross-linkers for epoxy resins, of compounds which can be rearranged in situ to difunctional phenols'1987 4,701,512'Isocyanate adducts with benzoxazolones or benzoxazinediones and use thereof as latent chain extenders or cross-linkers for epoxides'1987 4,661,578'High temperature epoxy resin composition with reduced viscosity'1987 4,631,331'Use, as latent cross-linkers for epoxy resins, of compounds which can be rearranged in situ to difunctional phenols'1986 4,631,332'Use of benzo-n-heterocycles to advance epoxy resins'1986 4,468,507'Method of limiting rate of heat evolution during acid-catalyzed phenol/polymethylolphenol condensations'1984 4,447,598'Method of preparing epoxy resins having low hydrolyzable chloride contents'1984

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1984–1995Patents assigned to DOW CHEMICAL CO (29)· patent assignee history

1984–1991Based in Lafayette, CA, US· patent location history

1989–1993Based in Walnut Creek, CA, US· patent location history

1994–1995Based in Alpharetta, GA, US· patent location history

1998–2000Patents assigned to 2C OPTICS INC (4)· patent assignee history

1998–2016Based in Danville, CA, US· patent location history

2003–2012Patents assigned to NEOMEND INC (5)· patent assignee history

2009–2016Patents assigned to INNOVATIONAL HOLDINGS LLC (8)· patent assignee history

2012–2016Patents assigned to PARKER THEODORE L (8)· patent assignee history

2016Based in Danvile, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
DOW CHEMICAL CO	29	1984–1995
INNOVATIONAL HOLDINGS LLC	8	2009–2016
PARKER THEODORE Lself	8	2012–2016
NEOMEND INC	5	2003–2012
2C OPTICS INC	4	1998–2000

Locations

Location	Patents	Span
Danville, California, US	31	1998–2016
Walnut Creek, California, US	14	1989–1993
Lafayette, California, US	13	1984–1991
Alpharetta, Georgia, US	3	1994–1995
Danvile, California, US	1	2016